Artificial Insemination Market – Overview

Global Artificial Insemination Market sees immense growth possibilities during the forecast period (2017-2023) where exceeding a total valuation of USD 1.95 billion mark is on the cards. In the process, the artificial insemination market can easily attain 10.9% CAGR over the forecast period.

Intrauterine Insemination is most common type of artificial dissemination. Artificial insemination helps to overcome problems in conceiving. This is one of the major advantages of artificial insemination. Increase in success rates of treatment of infertility favor the growth of artificial insemination. In the United States, 12 percent of women aged 15 to 44 years are unable to conceive after one year of unprotected sex.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/1218

According to the Centers for Disease Control and Prevention (CDC) suggest that a woman should consider seeing an infertility doctor to discuss treatment if she has not conceived within one year of trying to, has irregular periods, is over the age of 35, or has experienced two or more spontaneous miscarriages. Rising social acceptance has also played an important role in the growth of the global artificial insemination market. 

Increase in awareness about infertility and reproductive health and decrease in cost of treatment of fertility treatment drive the market for artificial insemination. Additionally, increasing healthcare expenditure and rapidly growing economies have fuelled the growth of the market. These factors are restraining the adoption of artificial insemination kits which could limit the growth of the global artificial insemination market.

Artificial Insemination Market - Key Players

• Labotect GmbH (Germany)
• Hamilton Throne Ltd. (U.S.)
• Microtech IVF S.R.O. (Czech Republic)
• Rinovum Women's Health LLC (US)
• Zander Scientific Inc. (U.S.)
• INVO Bioscience (U.S.)
• Nikon Instruments Inc. (U.S.)
• MedGyn Products Inc. (U.S.)
• Conceivex Inc. (US)
• Biogenics Inc. (U.S.)
• LifeGlobal Group LLC (U.S.)
• TenderNeeds Fertility (US)
• Surelife Pte Ltd. (Singapore)

Artificial Insemination Market - Segmentation

MRFR segments the Global Artificial Insemination Market by type and end-users for a better predictive analysis of the market over the forecast period. This segmentation is enriched with data containing both volume-wise and value-wise information.

Based on the type, the artificial insemination market can be segmented into intrauterine insemination, intracervical insemination, intratubal insemination, and other procedures. The intrauterine insemination segment has a significant market share owing to which the global market is looking promising.

Analysis with a focus on end-users reveals the artificial insemination market holding hospitals, clinics, fertility centers, and others as contributors to the holistic market growth. The clinics segment is contributing significantly.

Artificial Insemination Market - Regional Analysis

Depending on geographic region, artificial insemination market is segmented into four key regions: Americas, Europe, Asia-Pacific and Middle East and Africa. North America is the largest market. The cost of artificial insemination in America in between USD 300 to USD 500 per attempt. According to American Society of Reproductive Health, the typical success rate is 10 to 20 percent.  Continuous increasing in number of fertility clinics in the U.S and Canada, increase in drug addiction and smoking among women, unprotected sexual intercourse and rising trend of planned pregnancy favor the growth of this market in America. The European market is also growing continuously.

Deterioration of reproductive health among women, increased age of women at the time of pregnancy, rising income of families and demand of technological advancement in artificial insemination drive this market in Europe. Asia-Pacific market is expected to show fastest growth in the Artificial Insemination Market during the forecasted period. Rise in number of miscarriages, lack of awareness about reproductive health, increase in psychological and physical stress favor the growth of this market in Asia-Pacific. Government of India has number of programs for women in rural areas. In India, Janani Suraksha Yogana under National Health Mission was a great success initiating women to carry out institution delivery which provided cash assistance to pregnant women after delivery. Middle East and Africa show steady growth in this market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com